TransMedics Group, Inc.
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable…
Medical - Devices
US, Andover [HQ]
TMDX/Financial Reporting
Income Statements
8 Sheets · Starting from 2023In Million USD. Margins, Growth Rates In %
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.00 | 7.00 | 13.00 | 23.00 | 25.00 | 30.00 | 93.00 | 241.00 | |
|
EPS
|
-1.66 | -1.44 | -1.23 | -2.36 | -1.16 | -1.60 | -1.23 | -0.77 | |
| Diluted in mil. | -1.66 | -1.44 | -1.23 | -2.36 | -1.16 | -1.60 | -1.23 | -0.77 | |
|
Profit
|
- - | 2.00 | 5.00 | 13.00 | 16.00 | 21.00 | 65.00 | 153.00 | |
| Gross Margin | 12.34 | 27.81 | 44.05 | 58.73 | 64.88 | 69.92 | 69.84 | 63.73 | |
| Pre Tax | -24.00 | -20.00 | -23.00 | -33.00 | -28.00 | -44.00 | -36.00 | -26.00 | |
| Profit Margin | -387.58 | -270.54 | -182.18 | -141.95 | -112.00 | -145.99 | -38.70 | -11.04 | |
| ETR | -4.09 | -0.15 | -0.17 | -0.12 | -0.11 | -0.08 | -0.18 | 6.16 | |
| Net | -24.00 | -20.00 | -23.00 | -33.00 | -28.00 | -44.00 | -36.00 | -25.00 | |
| Profit Margin | -387.58 | -270.96 | -182.50 | -142.12 | -112.13 | -146.11 | -38.77 | -10.36 | |
| EBITDA | -22.00 | -19.00 | -19.00 | -28.00 | -24.00 | -40.00 | -32.00 | 8.00 | |
| EBITDA Margin | -363.26 | -250.46 | -151.19 | -122.07 | -96.46 | -133.19 | -34.71 | 3.63 | |
| Operating Income | -22.00 | -20.00 | -20.00 | -29.00 | -26.00 | -39.00 | -31.00 | - - | |
| Operating Margin | -370.20 | -265.79 | -155.47 | -125.42 | -102.91 | -130.29 | -33.64 | 0.20 | |
| Interest Income | - - | - - | - - | 1.00 | - - | - - | - - | 12.00 | |
| Loss | -29.00 | -28.00 | -33.00 | -53.00 | -52.00 | -69.00 | -124.00 | -241.00 | |
| Cost of Revenue | -5.00 | -5.00 | -7.00 | -9.00 | -9.00 | -9.00 | -28.00 | -87.00 | |
|
Operating Expenses
|
-23.00 | -22.00 | -25.00 | -43.00 | -43.00 | -60.00 | -96.00 | -153.00 | |
| R&D | -15.00 | -14.00 | -13.00 | -19.00 | -18.00 | -22.00 | -26.00 | -36.00 | |
| G&A | - - | -7.00 | -12.00 | -21.00 | -24.00 | -38.00 | -51.00 | -119.00 | |
| SG&A | -8.00 | -7.00 | -12.00 | -23.00 | -24.00 | -38.00 | -69.00 | -117.00 | |
| S&M | - - | - - | -1.00 | -2.00 | - - | -8.00 | -18.00 | -2.00 | |
| Depreciation and Amortization | - - | - - | - - | -1.00 | -1.00 | -1.00 | -3.00 | -8.00 | |
| Interest Expenses | - - | -1.00 | -2.00 | -4.00 | -3.00 | -3.00 | -3.00 | -10.00 | |
| Other Expenses | - - | - - | - - | -3.00 | -2.00 | -4.00 | -4.00 | -27.00 | |
|
WA Shares Outstanding
|
14.00 | 14.00 | 19.00 | 14.00 | 24.00 | 27.00 | 29.00 | 32.00 | |
| Diluted | 14.00 | 14.00 | 19.00 | 14.00 | 24.00 | 27.00 | 29.00 | 32.00 |